TAVI May Improve Cognitive Function in Patients with Prior Deterioration

Cognitive Function TAVIThis work studies cognitive evolution after transcatheter aortic valve implantation (TAVI). Previous smaller studies reported conflicting results on cognitive function after TAVI.

 

This study prospectively included 229 patients who were ≥70 years old, had undergone TAVI and were assessed using the Mini Mental State Examination before and 6 months after the procedure. Cognitive deterioration or improvement was defined as a decrease or increase in the Mini Mental State Examination score of at least 3 points between baseline and 6 months.

 

Cognitive deterioration was found in 29 patients (12.7%), although no statistically significant predictor of this event was identified. However, observation of the 8 patients with the highest deterioration score (Mini Mental State Examination score decrease of ≥5 points) revealed possible specific causes, such as postinterventional delirium, postinterventional stroke, progressive renal failure, progressive heart failure, or preexisting cerebrovascular disease.

 

There were 48 patients with baseline cognitive deterioration (Mini Mental State Examination score <26 points), of whom 18 (37.5%) improved significantly.

 

The preinterventional aortic valve area was lower in patients who cognitively improved after the procedure (mean baseline aortic valve area 0.6 cm²) when compared with patients whose score remained similar to their baseline score (mean baseline aortic valve area 0.7 cm²; p = 0.01).

 

Conclusion

This is the first study providing evidence that transcatheter aortic valve replacement may result in cognitive improvement among patients who had preprocedural cognitive impairment, which may be possibly related to hemodynamic improvement. This study also confirms that some patients experience cognitive deterioration after the procedure.

 

Original title: Evolution of Cognitive Function After Transcatheter Aortic Valve Implantation.

Reference: Andreas W. Schoenenberger et al. Circ Cardiovasc Interv. 2016 Oct;9(10).

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Cardiac Remodeling After Percutaneous ASD Closure: Should It Be Immediate or Progressive?

Atrial septal defect (ASD) is a common congenital heart disease that generates a left-to-right shunt, leading to right-side chamber overload and a risk of...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...